Furthermore, when human patients on PD were analyzed, serum AIM levels were significantly lower in patients who had previously experienced peritonitis than in those without peritonitis [39], suggesting that AIM has a protective role to play against peritonitis in PD patients. The gene discussed is CD5L; the disease is peritonitis.